Enanta Pharmaceuticals (ENTA) Share-based Compensation Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -20.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.05% |
| Dec 31, 2025 | -32.76% |
| Sep 30, 2025 | -47.73% |
| Jun 30, 2025 | -22.89% |
| Mar 31, 2025 | -15.70% |
| Dec 31, 2024 | -30.04% |
| Sep 30, 2024 | 14.92% |
| Jun 30, 2024 | -22.59% |
| Mar 31, 2024 | -24.47% |
| Dec 31, 2023 | 13.45% |
| Sep 30, 2023 | -1.71% |
| Jun 30, 2023 | -7.96% |
| Mar 31, 2023 | 13.78% |
| Dec 31, 2022 | 17.77% |
| Sep 30, 2022 | 27.65% |
| Jun 30, 2022 | 38.87% |
| Mar 31, 2022 | 22.56% |
| Dec 31, 2021 | 24.14% |
| Sep 30, 2021 | 12.81% |
| Jun 30, 2021 | 15.14% |
| Mar 31, 2021 | 6.09% |
| Dec 31, 2020 | -4.22% |
| Sep 30, 2020 | 5.16% |
| Jun 30, 2020 | 14.19% |
| Mar 31, 2020 | 5.74% |
| Dec 31, 2019 | -12.75% |
| Sep 30, 2019 | 9.78% |
| Jun 30, 2019 | 3.45% |
| Mar 31, 2019 | 31.11% |
| Dec 31, 2018 | 41.82% |
| Sep 30, 2018 | 28.04% |
| Jun 30, 2018 | 29.75% |
| Mar 31, 2018 | 2.81% |
| Dec 31, 2017 | 26.11% |
| Sep 30, 2017 | 27.89% |
| Jun 30, 2017 | 25.59% |
| Mar 31, 2017 | 46.60% |
| Dec 31, 2016 | 64.01% |
| Sep 30, 2016 | 39.68% |
| Jun 30, 2016 | 55.93% |
| Mar 31, 2016 | 66.57% |
| Dec 31, 2015 | 93.77% |
| Sep 30, 2015 | 126.04% |
| Jun 30, 2015 | 104.12% |
| Mar 31, 2015 | 90.16% |
| Dec 31, 2014 | 186.35% |
| Sep 30, 2014 | 177.97% |
| Jun 30, 2014 | 224.69% |
| Mar 31, 2014 | 192.61% |
| Dec 31, 2013 | 27.76% |
| Sep 30, 2013 | 17.70% |
| Jun 30, 2013 | 151.58% |
| Mar 31, 2013 | 729.03% |